Alvotech (ALVO) had its price target lowered by UBS Group AG from $10.00 to $6.00. They now have a "buy" rating on the stock.
Alvotech (ALVO) had its price target lowered by Barclays PLC from $5.00 to $4.00. They now have an "underweight" rating on the stock.
Alvotech (ALVO) was upgraded by Zacks Research from "strong sell" to "hold".
Did Alvotech's (ALVO) Profitability Turn and Expanding Biosimilar Pipeline Just Recast Its Investment Narrative? [Yahoo! Finance]
Alvotech (ALVO) Q4 2025 Earnings Call Transcript [Seeking Alpha]